Delay Condoms, and Whether Thicker Condoms Help You Last Longer

Condoms are regulated in the UK as medical devices rather than medicines. That single fact answers most of what people want to know here, and it is almost never mentioned on pages about these products.

Medicines are authorised for specific uses on the basis of evidence reviewed through the medicines system. Medical devices follow a conformity-assessment route instead, with requirements depending on the type of device. The MHRA regulates the device market and carries out surveillance, but registration itself is not an approval or endorsement of a product.

Some condoms are marketed specifically to help delay ejaculation. A manufacturer's marketing claim is not the same as clinical evidence that a product treats premature ejaculation.

This page covers what these products are, what their regulatory marking does and does not tell you, what evidence was identified, and one specific safety issue that matters if you have been prescribed the licensed topical treatment.

Key things to know

• These are medical devices. Medicines and devices are regulated under completely different systems
• The MHRA does not approve devices the way medicines are authorised. Devices must meet conformity-assessment requirements, with third-party assessment required for some
• A UKCA or CE mark indicates conformity with the applicable requirements. It is not a statement that a delay claim has been clinically proven
• Some are sold with a benzocaine lubricant. Benzocaine is a local anaesthetic, and it works by reducing sensation
• Extra thickness is a mechanism claim rather than an evidence claim. No trial data comparable to the licensed treatments was identified
• If you are prescribed the licensed cutaneous spray, it must not be used with polyurethane barrier products
• No device addresses the two things guidance says to deal with first

How These Products Are Regulated

The regulatory route explains why the marketing looks the way it does, and it is worth understanding before assessing any claim on a box.

Devices Are Not Medicines

For a medicine, the authorised indication, formulation and strength are supported by evidence submitted during authorisation. That is why licensed medicines come with an authorised indication and detailed information on their evidence, contraindications and side effects.

Medical devices follow a conformity-assessment route instead. Depending on the device and its classification, that can involve self-declaration, assessment by an approved body, and, where required, clinical evidence.

What a UKCA or CE Mark Tells You

UKCA stands for UK Conformity Assessed, a marking used for certain goods, including medical devices, placed on the Great Britain market. A valid CE marking allows a device to be placed on the EU market.

Both are conformity markings. They indicate the manufacturer has followed the applicable route and declared or demonstrated compliance with the relevant requirements. Neither is a guarantee that a product will never fail, and neither is a clinical endorsement of a delay claim.

What a Delay Product Actually Is

Two designs are sold under this heading, and they work on different principles.

The thicker design. A thicker barrier may alter how much stimulation is transmitted. The more important question is whether that translates into a meaningful improvement in control, and the evidence identified for this page does not establish that.

The benzocaine design. Benzocaine is a local anaesthetic that reduces sensation. Lidocaine and prilocaine, the active ingredients in the licensed spray, are also local anaesthetics, though from a different chemical class.

Does Extra Thickness Change Anything?

It reduces what is transmitted. Whether that reduction is enough to matter has not been established in any source reviewed for this page.

The Mechanism Claim and Its Limits

Thicker material transmitting less sensation is a plausible mechanism. Plausible mechanisms are how most unsupported health claims begin.

Elsewhere in this area, mechanism reasoning has repeatedly failed to survive testing. A mechanism explains how something might work. It does not show that it does.

Why the Placebo Problem Applies Here Too

In the pooled trials of the licensed tablet, the placebo group's measured time increased substantially, in men who did not know what they had been given. That is why comparing a treatment group against a control group is the only way to tell whether a product itself made the difference.

If you use a delay condom and find that things last longer, that is a real experience. What it cannot tell you is whether the cause was reduced sensation, your expectations, a change in arousal, or something else entirely.

Only a controlled trial separates those, and none comparable to the licensed treatments was identified for these products.

Start Your Free Assessment

The Evidence Position, Stated Plainly

The licensed tablet has a pooled analysis of five phase III randomised controlled trials covering 6,081 men, with mean measured time rising from 0.9 minutes to 3.1 minutes on the lower strength studied, against 1.9 minutes on placebo. 26.2% reported good or very good control, against 11.2% on placebo.

The licensed cutaneous spray has two randomised controlled trials covering 539 patients, with mean measured time rising from 0.58 minutes to 3.17 minutes, against 0.56 to 0.94 minutes on placebo.

Nothing equivalent was identified for delay devices.

One Safety Point if You Use the Licensed Spray

This is the most practically useful item on the page, and it is easy to miss.

The licensed lidocaine and prilocaine cutaneous spray must not be used with polyurethane barrier products. Its product information records latex rubber, polyisoprene, nitrile and silicone as compatible materials.

This gets missed because the prescription is handled in one place and the barrier product is bought somewhere else entirely. Nothing connects the two unless somebody says it out loud.

Anyone prescribed the spray should check what their barrier product is made from. That is a thirty-second check on the packaging, and getting it wrong means a product that may not perform as intended.

Benzocaine, and the Questions a Device Does Not Answer

Sensitivity and Allergic Reaction

Benzocaine is a local anaesthetic, and local anaesthetics can cause allergic reactions.

Signs worth taking seriously are a rash spreading beyond the area of contact, swelling, raised welts, itching away from the site, difficulty breathing, or any swelling of the face, lips or throat. The last group needs emergency medical help.

Anyone with a known sensitivity to any local anaesthetic, including a reaction at the dentist, should treat an anaesthetic lubricant as something to check rather than assume.

Transfer to a Partner

An anaesthetic in a lubricant can reach a partner. That is inherent to the format.

For the licensed spray, partner effects are recorded with frequencies: a burning sensation in 3.9%, reduced sensation in 1.0%, and discomfort leading to discontinuation in 0.3%. Its contraindication also extends to a partner with a history of sensitivity to amide-type local anaesthetics.

For a device carrying an anaesthetic lubricant, no equivalent figures were identified. The transfer question exists either way. Only one of the two has answers attached to it.

Fit, Regardless of Any Delay Claim

Correct fit matters for proper use, and can help reduce problems such as slippage or breakage. That is a reason to get fit right for its own sake, and it is separate from whether thickness or fit improves ejaculation control.

Where fit is being adjusted in pursuit of reduced sensation, the reasoning has drifted from what the product is assessed for into a claim nobody has verified.

How the Options Compare

The device column is not a budget version of the others. It is a product assessed for a different purpose, sold alongside a claim its regulatory route never examined.

Using a Device as a First Step

Some people would rather try something readily available before seeking medical advice. That is understandable, and it is different from starting a prescription medicine.

The thing to keep realistic is what can be concluded from it. Using one does not establish what is causing the difficulty, or whether a different treatment is needed.

What It Does Not Replace

A condom does not assess the reasons behind premature ejaculation. Guidance recommends distinguishing it from erectile dysfunction and from other conditions including prostatitis, and where those are present they may need addressing first.

When the Device Question Is the Wrong One

• Erectile difficulty is present as well
• Urinary symptoms, discomfort or bleeding
• A sudden change after a settled period, particularly with other symptoms
• Persistent distress or relationship difficulty
• Pain on ejaculation, blood present, or ejaculate volume that has dropped noticeably
• Any reaction to an anaesthetic lubricant, in either person

Buying These Products

The question people ask is where to get them. The more useful question is how to tell whether what arrives is what it claims to be.

1. Look for a UKCA or CE conformity marking on the packaging
2. Check the material, particularly if you are prescribed the licensed cutaneous spray
3. Check whether an anaesthetic lubricant is present, and whether either person has any history of local anaesthetic sensitivity
4. Treat a delay claim as a marketing statement rather than an assessed finding, because under the device route that is what it is

A registered pharmacy is accountable to a regulator for what it supplies and how. General Pharmaceutical Council registration can be checked on the regulator's own register, which is a verification step no marking on a box provides.

The Claims This Page Stops Short of Making

• No delay device is described here as ineffective in the sense of having been tested and failed. No comparable trial data was identified, which is a different and more accurate statement
• No product is named, recommended or ranked, because no assessed basis for ranking exists
• No quantity of anaesthetic delivered by a device is stated, because none is established for this purpose
• No claim is made about how any device performs at the purpose it is actually assessed for, which is outside the scope of this page
• No off-licence use of any medicine is endorsed
• No individual outcome is predicted. Results vary between individuals

Medical Disclaimer

This page provides general information about delay condoms and how they are regulated. It is not a diagnosis, and does not provide treatment advice. Treatment suitability depends on an individual clinical assessment.

Explore PE Treatment Options